Article Australia Harm–benefit balance Medicine safety Quality use of medicines alemtuzumab antidepressant agent antidiabetic agent apixaban bisphosphonic acid derivative celecoxib cholinesterase citalopram clinical outcome clinical practice dabigatran dementia denosumab diclofenac donepezil drug marketing drug quality drug safety drug utilization duloxetine escitalopram fluoxetine fluvoxamine galantamine government